Mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty city, Kazakhstan
DOI:
https://doi.org/10.56294/saludcyt20241328Keywords:
Chronic Kidney Disease, Mortality, Immunity, Haemodialysis, SARS–Cov–2Abstract
Objetive: to determine the rate of mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty City, Kazakhstan.
Methods: patients with coronavirus infections who were hospitalized at a hospital in the Kazakhstani Almaty region from June 2020 until June 2022 are included in the retrospective analysis. The Unified National Electronic Healthcare System (UNEHS) provided the database extraction. Individuals were considered eligible if they had been admitted to the hospital with the primary diagnoses of U07.1 (COVID-19, detected virus) and U07.2.
Conclusion: in Almaty, Kazakhstan, hospitalization outcomes for coronavirus patients with and without chronic kidney disease were assessed in this study. Analysis was done on the impact of comorbidities and sociodemographic characteristics on mortality. While there are many ways to prevent and manage chronic kidney disease (CKD), coexisting medical diseases, particularly viruses that cause pandemics, might complicate matters. Thus, to prevent unplanned infectious disease outbreaks, a thorough disease management plan must be established
References
1. Garazhayeva L, Gaipov A, Zhakhina G, Kim V, Gusmanov A, Sakko Y, et al. WCN23-0601 Mortality of Patients With Ckd and its Risk Factors Admitted to Hospital With Covid-19 in Almaty City Kazakhstan Between 2020-2022. Kidney Int Rep [Internet]. 2023;8(3):S459–60. Available from: http://dx.doi.org/10.1016/j.ekir.2023.02.1031
2. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022 Apr;12(1):7–11. Doi/10.1016/j.kisu.2021.11.003
3. Ammirati AL. Chronic Kidney Disease. Rev Assoc Med Bras. 2020;66(suppl 1):s03–9.
4. Forbes A, Gallagher H. Chronic kidney disease in adults: assessment and management. Clin Med (Northfield Il). 2020 Mar;20(2):128–32.
5. Serhiyenko V, Holzmann K, Holota S, Derkach Z, Nersesyan A, Melnyk S, et al. An exploratory study of physiological and biochemical parameters to identify simple, robust and relevant biomarkers for therapeutic interventions for PTSD: study rationale, key elements of design and a context of war in Ukraine. Proc Shevchenko Sci Soc Med Sci. 2022;69(2).
6. Charles C, Ferris AH. Chronic Kidney Disease. Prim Care Clin Off Pract. 2020 Dec;47(4):585–95.
7. Maltsev D, Stefanyshyn V. The efficacy of combined immunotherapy with Propes and Inflamafertin in adult patients with genetic deficiency of the folate cycle and selective deficiency of NK and NKT cells. Immunology. 2022 Nov;167(3):443–50.
8. Maltsev, D., & Bokova S. Innovative Development of the Health Care Sector of the Future in the Conditions of Modern Challenges of the Covid-19 Coronavirus Infection in Ukraine. Futur Med. 2022 Mar;4–16.
9. Zhylin M, Makarenko S, Kolohryvova N, Bursa A, Tsekhmister Y. Risk Factors for Depressive Disorders after Coming through COVID-19 and Emotional Intelligence of the Individual. J Intellect Disabil - Diagnosis Treat. 2022 Oct;10(5):248–58.
10. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID‐19 diagnosis and management: a comprehensive review. J Intern Med. 2020 Aug;288(2):192–206.
11. Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021 Mar;18(5):2621.
12. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022 Jun;20(3):1537–45.
13. Hussain N. The correlation between risk factors of COVID-19 and nervous system damage: Pakistan based Analysis. Futur Med. 2022 Sep;22–9.
14. Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021 Jan;93(1):250-6.
15. Baig S. Change in physical and mental health due to aging: future perspective. Futur Med. 2023 Mar;13–23.
16. Yıldırım M, Akgül Ö, Geçer E. The Effect of COVID-19 Anxiety on General Health: the Role of COVID-19 Coping. Int J Ment Health Addict. 2022 Apr;20(2):1110–21.
17. Zhong BL, Luo W, Li HM, Zhang QQ, Liu XG, Li WT, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745–52.
18. Krasnova A. Vaccination of pregnant women against COVID-19 under martial law: a narrative review. Futur Med. 2022 Jun;4–12.
19. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chinese Med Assoc. 2020 Mar;83(3):217–20.
20. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. J Adv Res. 2020 Jul;24:91–8.
21. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2021 Feb;64(1):66–74.
22. Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. COVID-19: An overview and a clinical update. World J Clin Cases. 2021 Jan;9(1):8–23.
23. Hernandez Acosta RA, Esquer Garrigos Z, Marcelin JR, Vijayvargiya P. COVID-19 Pathogenesis and Clinical Manifestations. Infect Dis Clin North Am. 2022 Jun;36(2):231–49.
24. Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022 Mar;43(11):1157–72.
25. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post‐COVID‐19 manifestations. Int J Clin Pract. 2021 Mar;75(3).
26. Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and Clinical Characteristics of COVID-19. Arch Iran Med. 2020 Apr;23(4):268–71.
27. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021 Apr;199(2):113–9.
28. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433.
29. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021 Jan;101(1):303–18.
30. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID‐19 based on current evidence. J Med Virol. 2020 Jun;92(6):548–51.
31. Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2021 Apr;54(2):159–63.
32. Parnell D, Widdop P, Bond A, Wilson R. COVID-19, networks and sport. Manag Sport Leis. 2022 Mar;27(1–2):78–84.
33. Daniel SJ. Education and the COVID-19 pandemic. Prospects. 2020 Oct;49(1–2):91–6.
34. Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021 Jun;17(6):1612–21.
35. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71–6.
36. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021 Aug;38:101019.
37. Narayanan M, Setia S. Chronic Kidney Disease. In: The Perioperative Medicine Consult Handbook. Cham: Springer International Publishing; 2020. p. 301–5.
38. Iorember FM. Malnutrition in Chronic Kidney Disease. Front Pediatr. 2018 Jun;6.
39. Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC. Hypoxia and chronic kidney disease. eBioMedicine. 2022 Mar;77:103942.
40. Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022 Nov;53:101624.
41. Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020 Aug;57(6):365–88.
42. Hebert SA, Ibrahim HN. Hypertension Management in Patients with Chronic Kidney Disease. Methodist Debakey Cardiovasc J. 2022 Sep;18(4):41–9.
43. Cao YL, Lin JH, Hammes HP, Zhang C. Flavonoids in Treatment of Chronic Kidney Disease. Molecules. 2022 Apr;27(7):2365.
44. Kramer H. Diet and Chronic Kidney Disease. Adv Nutr. 2019 Nov;10:S367–79.
45. Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, et al. Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2021 Dec;78(6):804–15.
46. Pawar N, Tiwari V, Gupta A, Bhargava V, Malik M, Gupta A, et al. COVID-19 in CKD patients: Report from India. Indian J Nephrol. 2021;31(6):524.
47. Xu C, Zhang T, Zhu N, Han M. Characteristics of COVID-19 patients with preexisting CKD history. Int Urol Nephrol. 2021 Dec;53(12):2567–75.
48. Pakhchanian H, Raiker R, Mukherjee A, Khan A, Singh S, Chatterjee A. Outcomes of COVID-19 in CKD Patients. Clin J Am Soc Nephrol. 2021 May;16(5):785–6.
49. Akchurin O, Meza K, Biswas S, Greenbaum M, Licona-Freudenstein AP, Goyal P, et al. COVID-19 in Patients with CKD in New York City. Kidney360. 2021 Jan;2(1):63–70.
50. Leibler JH, Keogh SA, Jarquín E, Garcia-Trabanino R, Velázquez JJA, Pilarte DL, et al. COVID-19 and CKD: Employment, Food Security and Healthcare in El Salvador. Ann Glob Heal. 2022 Nov;88(1).
51. Bayesheva D, Boranbayeva R, Turdalina B, Fakhradiyev I, Saliev T, Tanabayeva S, et al. COVID-19 in the paediatric population of Kazakhstan. Paediatr Int Child Health. 2021 Jan;41(1):76–82.
52. Seilkhan A, Abdrassulova Z, Erkaebaeva M, Soltan R, Makhambetov M, Ydyrys A. Problems of distance education in Kazakhstan during the COVID-19 pandemic. World J Educ Technol Curr Issues. 2022 Mar;14(2):380–9.
53. Zhussupov B, Saliev T, Sarybayeva G, Altynbekov K, Tanabayeva S, Altynbekov S, et al. Analysis of COVID-19 pandemics in Kazakhstan. J Res Health Sci. 2021 May;21(2):e00512–e00512.
54. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829–38.
55. Uribarri A, Núñez-Gil IJ, Aparisi A, Becerra-Muñoz VM, Feltes G, Trabattoni D, et al. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 Aug;33(4):737–45.
56. Portolés J, Marques M, López-Sánchez P, de Valdenebro M, Muñez E, Serrano ML, et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant. 2020 Aug;35(8):1353–61.
57. Abrishami A, Khalili N, Dalili N, Khaleghnejad Tabari R, Farjad R, Samavat S, et al. Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD. Iran J Kidney Dis. 2020 Jul;14(4):267–77.
58. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430–6.
59. Appelman B, Oppelaar JJ, Broeders L, Wiersinga WJ, Peters-Sengers H, Vogt L, et al. Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort. Sci Rep. 2022 Feb;12(1):2258.
Published
Issue
Section
License
Copyright (c) 2024 Garazhayeva Laura, Gaipov Abduzhappar, Kauysheva Almagul (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
